News

Chambers Europe 2020 about BarentsKrans: hyper-intelligent & down to earth

Chambers Europe 2020, the guide that provides an overview of law firms and lawyers in Europe, has just been released. We are very proud to have received numerous honourable mentions once again. BarentsKrans has been ranked in six different practice areas. Ten of our lawyers have been recommended by name. Chambers is one of the
Read more ›

Rankings Chambers Global 2020: again great results for BarentsKrans

Chambers Global 2020 was published today, the guide that provides a global overview of five international jurisdictions. BarentsKrans has a number of wonderful mentions for Corporate/M&A, Intellectual Property and Dispute Resolution. Feedback from clients and peers The yearly Chambers ranking lists are based upon feedback received from clients as well as peer reviews. Chambers is
Read more ›

Telecoms update | Provisions judge denies Fractus a preliminary injunction against Xiaomi et al.

On 10 December 2019, the Provisions Judge of the District Court of The Hague denied a cross-border preliminary injunction claimed by FRACTUS S.A. (‘Fractus’) against Xiaomi Technology Netherlands B.V. (‘Xiaomi’) and several Dutch smartphone vendors for the alleged infringement of Fractus’ patent EP 1 592 083 (‘EP ‘083’). According to Fractus the antennas of various
Read more ›

Telecoms update: ‘Better Network’ campaign KPN not unlawful, rules District Court

Our Telecoms Update of 30 July 2019 is about the recent decision of the The Hague District Court in KPN v T-Mobile. The Court ruled that KPN’s advertising campaign ‘Better Network, Better Life’ did not constitute unlawful comparative advertising and rejected T-Mobile claims in full. The judgment means that KPN is allowed to continue its very successful advertising campaign. BarentsKrans represented KPN in this case.
Read more ›

Pharma update: pemetrexed tromethamine does not infringe pemetrexed disodium patent

In its judgment of 19 June 2019, the District Court of The Hague ruled that Fresenius Kabi’s pemetrexed tromethamine falls outside the scope of protection of Eli Lilly’s patent for pemetrexed disodium. This final relief decision deviates from earlier decisions in interim relief proceedings and decisions by several foreign courts. Eli Lilly (“Lilly”) markets the
Read more ›